Pantozol (Pantoprazole)

Pantoprazole irreversibly inhibits the H+/K+ ATPase enzyme, also known as the gastric proton pump, in the parietal cells of the stomach. This blockade stops the final step of acid production, leading to a sustained increase in gastric pH and reduced acidity.

The specific dose and treatment duration of Pantozol are determined by the prescribing clinician based on the patient’s condition, severity, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Pantoprazole should be used in pregnancy or while breastfeeding only if the potential benefit outweighs any possible risk to the fetus or infant. The decision must be made by a healthcare professional after evaluating the individual situation.

To request Pantozol, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Pantoprazole, the active ingredient in Pantozol, shares the same class mechanism as other PPIs such as omeprazole and esomeprazole. It is distinguished by a relatively low potential for drug‑enzyme interactions and is often preferred when patients are on multiple medications that are metabolized by CYP450 enzymes.

Store Pantozol tablets at room temperature, below 25 °C, in the original container. Keep them away from moisture, heat and direct sunlight to maintain product stability.

Pantozol is taken orally, usually as a whole tablet swallowed with water. It is generally recommended to take the medication before a meal, but patients should follow the specific instructions provided by their healthcare provider.

Serious adverse reactions, though rare, can include severe allergic responses such as anaphylaxis or Stevens‑Johnson syndrome, Clostridium difficile‑associated diarrhea, low magnesium levels, liver injury, pancreatitis, and kidney inflammation. Patients should seek immediate medical attention if they experience any of these symptoms.

Pantozol should be avoided in individuals with known hypersensitivity to pantoprazole or other proton pump inhibitors. Caution is also advised for patients with severe liver disease, those on certain interacting medications, and pregnant or breastfeeding women unless the prescriber determines the benefits outweigh the risks.